Objectives-Achieving adequate growth following stage 1 palliation for children with single ventricle heart defects often requires supplemental nutrition through enteral tubes. Significant practice variability exists between centers in choice of feeding tube. The impact of feeding modality on growth of single ventricle patients following stage 1 palliation was examined using the multi-institutional National Pediatric Cardiology Quality Improvement Collaborative data registry.
Introduction
Although operative survival continues to improve following stage 1 palliation (S1P) for children with single ventricle heart lesions, the interstage period, from discharge following S1P until stage 2 palliation (S2P), continues to be a high-risk time with reported mortality of 2-20% (1-6). Growth and feeding problems are common in these infants and may have a significant impact on outcomes (7-10). Historically, patients with hypoplastic left heart syndrome (HLHS) and other single ventricle variants requiring S1P have demonstrated poor growth during neonatal hospitalization and the interstage period which has been attributed to a variety of factors, including high metabolic demands in the face of inadequate oral intake as well as the inability to safely feed by mouth due to co-morbidities. Previous studies have demonstrated that in order to ensure normal growth, 18-75% of patients require supplementation with either nasogastric (NG) or gastrostomy tube (GT) at the time of discharge after S1P (7, 11, 12). The implementation of an interstage home monitoring program including daily recording of weight and intake has been associated with improved survival as well as normal growth outcomes, and has been adopted by many programs (9, 12-15). There is considerable variation in feeding modality chosen when supplementation is required, and there may be important differences between children able to feed orally versus those fed via NG or GT (9, 14, [16] [17] [18] . The inability to achieve normal growth and to feed orally may be surrogates of more severe illness and vulnerability (2, 12, (19) (20) (21) . Recent single center studies have demonstrated conflicting results for morbidity and mortality in single ventricle patients fed by NG versus GT (2, 10, 19, 22) . No study to date has compared growth between feeding modalities in single ventricle patients using multi-institutional data.
The National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) is a multicenter quality improvement collaborative with a primary aim "To reduce mortality and improve the quality of life in infants with HLHS during the interstage period" (23) . Based on prior studies demonstrating an association between growth and improved outcomes, the NPC-QIC has identified improvement in interstage growth as a primary driver to achieve improved overall outcomes (23) . Using data from 47 institutions contributing to the NPC-QIC, we sought to 1) describe the differences in patient characteristics between feeding modality groups, and 2) compare growth outcomes during the interstage period by feeding modality.
Methods

Study Design and Measurements
This was a retrospective analysis of subjects enrolled in the NPC-QIC registry. The NPC-QIC is a collaborative of 47 pediatric cardiac programs that includes a voluntary registry of subjects discharged home following S1P, which includes surgical palliation or the hybrid alternative. Individual participating sites obtain institutional review board approval and parental informed consent. There is a standard dataset with data definitions, online webbased data entry, and data quality checks. The de-identified data are housed in a secure server at the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center. Individual programs complete detailed data forms consisting of demographic data, birth information, surgical information, as well as clinical variables collected at the time of discharge and at each subsequent visit until discharge from S2P.
Subjects completing S2P between June 2008 and July 2012 were included. Interstage deaths were excluded. The cohort was divided into five groups based on the feeding modality at discharge from S1P: 1) those fed exclusively by mouth (PO only); 2) exclusively by NG tube (NG only); 3) by a combination of oral and NG tube (PO + NG); 4) exclusively by G tube (G tube only); 5) and a combination of oral and G tube (PO + G tube). Indications for preferred feeding modality and morbidity associated with specific enteral tubes were not available in the database.
Demographic data collected was limited to gender and race/ethnicity, which was categorized as white, black or African American, Hispanic or other. Pre-operative factors collected included gestational age, cardiac diagnosis which for analysis was dichotomized to HLHS versus non-HLHS, presence of any known genetic syndrome or other chromosomal anomaly as well as presence of any other organ system anomalies. Pre-operative risk factors recorded were mechanical ventilation and a composite complication variable which included pre-operative arrhythmias requiring treatment, shock or acidosis, renal insufficiency, septicemia, necrotizing enterocolitis, and seizures. Post-operative complications were considered the need for ECMO, prolonged mechanical ventilation (>14 days), vocal cord paralysis or a composite variable consisting of cardiac arrest, arrhythmia requiring therapy, pneumonia or tracheitis, acute renal failure, wound infection or mediastinitis, diaphragm paralysis, seizures or necrotizing enterocolitis. Feeding method at discharge from S1P and readmission for S2P as well as target caloric intake at both times were collected. Anthropomorphic data included weights at birth, discharge from S1P and readmission for S2P. These were converted to weight for age z-scores (WAZ) to adjust for variation in ages.
Statistical Analysis
Descriptive data are presented as count and percent, mean with standard deviation, or median with range as appropriate. For the purposes of analysis, feeding modality at time of discharge was used as the grouping variable. Comparison between groups for categorical data was performed using Chi-square test, or Fisher's exact test where required by insufficient numbers, and ANOVA or Kruskal-Wallis test for continuous data based on distribution. Multivariable linear regression was used to determine risk factors for poor interstage growth. A significance level of p≤0.05 was used throughout. All statistical analyses were performed using SAS version 9.2 (SAS Institute Inc, Cary, North Carolina).
Results
A total of 465 patients who completed S2P had a weight documented at the time of S2P and were included in the study. At S1P discharge, 56% required supplementation of intake with a feeding tube, with the feeding group breakdown shown in Figure 1 . There was improvement in oral intake during the interstage period with a decrease to 37% requiring supplementation at the time of S2P, with significant cross-over between groups. Within the cohort 193/465 (41.5%) patients had a change in their feeding modality during the interstage period with the PO + NG group accounting for 90 (47%) of those 193 patients. A GT was placed during the interstage period in 23 patients. The indications for a change in feeding modality are not documented in the NPC-QIC database.
Comparison of characteristics between groups can be seen in Table 1 . Pre-operatively, the NG only, GT only and PO + GT groups were more likely to have other organ system anomalies and the GT only group was more likely to require pre-operative mechanical ventilation. Postoperatively, compared with the PO only group, those in the GT only and PO + GT groups more frequently required ECMO and had vocal cord paralysis. There were statistically significant differences in the types of S1P performed by feeding modality but no clear pattern was evident.
Mean weight gain was 7.7 ± 13 grams per day from birth to discharge after S1P, at a mean age of 42.4 ± 27.7 days. All groups had a decrease in WAZ during this period with a mean WAZ at birth of −0.5 ± 1.0, and a mean WAZ at discharge of −1.5 ± 0.9. During the interstage period the mean weight gain improved to 22.4 ± 6.5 grams per day with a mean change in WAZ of 0.3 ± 0.8 during this period, resulting in a final mean WAZ of −1.3 ± 1.1 at S2P. Growth by feeding modality from birth to S2P can be seen in figure 2. There was no difference in the change in WAZ between groups (p=0.96) during the interstage period. Mean target caloric goal at discharge from S1P was 120 ± 12.5 kcal/kg/day. Figure 3 displays the time spent in the hospital, intubated, and in the interstage period between groups. Patients in the GT only and PO + GT groups had significantly longer periods of intubation (p<0.001) and longer hospitalization following S1P (p<0.001). In multivariable analysis (adjusted R 2 = 0.07) the effect of feeding modality on change in WAZ was not significant (p=0.79). Significant risk factors for worse growth were a diagnosis of HLHS (p=0.002), a diagnosis of vocal cord injury (p=0.007) and having a lower documented target caloric intake at discharge from S1P (p=0.001). All factors included in the initial model can be seen in table 2. The mean difference between change in WAZ during the interstage period for those with a diagnosis of HLHS versus those without was −0.3 (95% confidence interval −0.6-− 0.1) and for vocal cord injury was −0.5 (95% confidence interval −0.8-−0.1) versus those without vocal cord injury. For every 10 kcal/kg/day increase in target caloric intake at discharge there was an increase of 0.15 in the WAZ at readmission for S2P.
Discussion
In this large multi-institutional database review of infants with single ventricle heart disease, there was a positive change in WAZ during the interstage period across all groups. Interstage growth was found to be the same between feeding groups with no growth advantage found in selecting one mode of supplemental tube feeding over another. This result is important given the focus on nutrition and growth in this population, and the impact of normal growth on improving outcomes. In addition, previous research has highlighted the considerable variability in practice between centers in regards to the choice of feeding modality when supplementation by feeding tube is required (7, 10, 12, 17, 24) . The reasons for this variability are unclear, and may represent differences in patient characteristics as well as individual provider or center-specific practice patterns and preferences when submitting high-risk patients for elective, non-cardiac surgery. This analysis was not designed to test differences in morbidities specific to the choice in feeding modality, such as complications related to feeding tube placement. However, this description of the characteristics of a large cohort helps define the needs of this vulnerable patient population and helps predict those patients most at risk for poor outcomes.
Prior to the use of home monitoring programs for infants with single ventricle heart disease, growth failure during the interstage period was a frequent finding of interstage outcome studies (7, 12-14, 17, [25] [26] [27] . Over numerous studies, a typical growth pattern for these patients has emerged, characterized by a large decrease in WAZ from birth to S1P discharge, followed by a less precipitous but continued decline in WAZ during the interstage period (12, 14, 17, 26, 27) . Previous data have shown the consequence of poor weight gain as poor growth and feeding problems are associated with earlier S2P, longer hospitalization after S2P and higher mortality (7, 9). However, recent single center experience from programs utilizing home monitoring programs with intense nutritional monitoring and intervention demonstrate that catch up growth can occur during the interstage period and is associated with improved outcomes in comparison to historical controls (9, 12, 13). A previous NPC-QIC study demonstrated significant institutional variation in the management and outcomes of interstage growth. Institutions employing home monitoring, red flags for poor growth, frequent phone contact and feeding evaluations after S1P demonstrated the best growth (24) . Our current analysis demonstrates a decline in WAZ from birth to S1P discharge, however, the improvement in interstage growth previously demonstrated only in single center studies is sustained across programs in this cohort, with an overall increase in WAZ during the interstage period. The decline in WAZ early can be anticipated as the perioperative period can be characterized by critical illness, fluid limitations, intolerance of enteral feeds and higher metabolic demands. All of these problems are less likely to be experienced during the interstage period, allowing for this catch-up growth.
While supplementation of oral intake with tube feeding may be required to achieve normal growth in a safe and effective manner, the ideal choice of feeding modality remains unclear (7, 11, 12). Hebson et al retrospectively reviewed their experience with patients undergoing single ventricle palliation between 2003 and 2010. They noted higher mortality in the cohort that underwent GT placement with or without Nissen fundoplication. Ultimately, they hypothesized that the need for GT may be a marker of an unknown risk factor for mortality (10). A secondary analysis of the Single Ventricle Reconstruction trial cohort found, in univariate analysis, that the inability to feed orally at the time of discharge was a risk factor for mortality. In contrast to the Hebson study, patients discharged with NG tubes were found to have higher mortality than those with GT (2). Previous work by Cross et al using data from the NPC-QIC found that patients with their last documented feeding route being NG had a relative risk of 5.5 (1.5-20.1) for interstage death versus those receiving all oral or GT feeds (22) . Using a single center experience, Di Maria et al compared single ventricle patients by feeding modality. They categorized patients into 3 groups (oral only, any NG intake, or any GT intake) based on feeding modality at discharge from S1P. While they found no difference in interstage mortality they did note those receiving supplementation of feedings were more likely to have undergone a Norwood procedure (versus shunt placement) and had a longer initial hospital course. They also noted that those receiving supplementation of feedings had significantly lower WAZ at discharge and the gap persisted until S2P (19) .
We found important differences in baseline characteristics between those requiring GT placement and the rest of the cohort: they had a greater decline in WAZ during the initial hospitalization, they had the lowest WAZ as a group at the time of S2P, they had more high risk features including the presence of an extracardiac anomaly, and a more complicated hospital course with a higher incidence of pre-operative intubation, vocal cord paralysis, ECMO, and prolonged post-operative ventilation. Data are unavailable as to whether one or more of these co-morbidities were the predominant indications for GT placement. Furthermore, it is likely the early growth of these patients is impacted by risk factors or altered physiology not captured in this analysis. The baseline differences between groups are the probable cause of the increased length of intubation and hospitalization seen in the NG only, GT only and PO + GT groups. The older age at S2P in the GT only and GT + PO groups is likely multi-factorial but may be in part a result of the longer initial hospitalization in those groups.
As a retrospective cohort, this study is subject to limitations in data collection. Only data collected by the NPC-QIC was available and these data may be influenced by center-specific practice, patient selection bias and partial data-sets for some patients. Additionally, as a multi-institution collaborative there are variations in practice that may contribute to differences seen. This is evident in the diagnosis of vocal cord injury where some institutions opt for universal screening while other only evaluate symptomatic infants. Additionally, only those surviving to S2P were included in the analysis with potential skewing of mortality to favor one group and possibly occurring predominantly in those struggling to grow. Finally, we elected to use the modality of feeding at discharge for classification as this represented a point of stability for patients and parallels an intention to treat analysis; however the timing and effect of interstage crossover in feeding modality is unknown.
Conclusion
Feeding modality did not impact interstage growth in patients after stage 1 palliation, with all feeding modalities showing an increase in growth velocity during this time period.
Factors that negatively influence growth during the interstage period are a diagnosis of HLHS, vocal cord injury and a lower target daily caloric intake at discharge from S1P. There are significant differences in the population requiring G tubes placed that increase length of hospitalization following S1P. Continued focus on growth during neonatal hospitalization may identify additional risk factors for growth failure and ultimately improve outcomes. Change in WAZ over time. Weights shown were obtained at Birth, S1P discharge and S2P admission. PO -oral; NG -nasogastric; GT -gastrostomy tube; WAZ -weight for age zscore. Duration of pre-S1P period, intubation, hospitalization and interstage period by feeding modality at discharge from stage 1 palliation. #Significantly longer interval (p<0.05) than other groups by ANOVA. PO -oral; NG -nasogastric; GT -gastrostomy tube; S1P -stage 1 palliation. Table 1 Characteristics by Feeding Modality
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